BCL2L1 and melanoma: Treatment of melanoma BCL-XL overexpressing clone with the BCL-XL selective inhibitor WEHI-53928 corroborated the experiments with BCL-XL siRNA knockdown: a significant reduction of both migration and invasion was observed after treatment with WEHI-539 (Fig. 2c).